Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Newly Diagnosed SLE Patients Have a Greater Risk of Cardiovascular Disease

Arthritis Care & Research  |  

This finding suggests inflammation has a potential pathogenic role in the development of myocardial infarction and stroke in SLE patients. Researchers conclude by emphasizing the value of routine evaluation of cardio vascular risk factors for SLE patients. “Additional research is also needed to investigate strategies to minimize the inflammatory response associated with increased [cardiovascular disease] risk, especially in the early stages of SLE,” they write. “Research could also investigate whether early aggressive treatment of inflammatory processes objectively decreases [cardiovascular disease] incidence.”

Read the full article. 

ADVERTISEMENT
SCROLL TO CONTINUE

Aviña-Zubieta JA, To F, Vostretsova K, et al. Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: A general population-based study. Arthritis Care Res (Hoboken). 2017 Jan 27. doi: 10.1002/acr.23018. [Epub ahead of print]

Related Articles
    A Comprehensive Review of NSAID Cardiovascular Toxicity

    A Comprehensive Review of NSAID Cardiovascular Toxicity

    Non-steroidal anti-inflammatory drugs (NSAIDs) are the most used drugs for acute and chronic pain. More than 30 billion doses of NSAIDs are consumed annually from more than 70 million prescriptions.1 Despite their common use, NSAIDs are not free of serious toxicities. In the pre-Vioxx (rofecoxib) era, gastrointestinal toxicity was the primary concern for many NSAIDs….

    A Heart In Danger

    Rheumatologists should monitor and aggressively treat cardiac risk factors in patients with lupus and rheumatoid arthritis

    APS: What Rheumatologists Should Know about Hughes Syndrome

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

    The Heart-SCC Puzzle

    Identifying and treating cardiac involvement in systemic sclerosis can be a challenge